Overview

TVB- 2640 in Combination With Bevacizumab in Patients With First Relapse of High Grade Astrocytoma

Status:
Active, not recruiting
Trial end date:
2021-04-10
Target enrollment:
Participant gender:
Summary
Randomized phase 2 study TVB-2640 in combination with Bevacizumab versus Bevacizumab alone.
Phase:
Phase 2
Details
Lead Sponsor:
The University of Texas Health Science Center at San Antonio
Treatments:
Bevacizumab